Literature DB >> 10764769

Species-specific alternative splice mimicry at the growth hormone receptor locus revealed by the lineage of retroelements during primate evolution.

J Pantel1, K Machinis, M L Sobrier, P Duquesnoy, M Goossens, S Amselem.   

Abstract

In humans, growth hormone receptor (GHR) transcripts exist in two isoforms differing by the retention (GHRfl) or exclusion (GHRd3) of exon 3, whereas in mice GHRfl is solely expressed. This species-specific expression pattern is believed to result from an alternative splice event that, on the basis of conflicting data obtained in humans, has been considered to be tissue-, developmentally, and/or individual-specific. To decipher the molecular basis of this unusual trait, we isolated a 6.8-kilobase fragment spanning exon 3 from individuals expressing GHRfl. Sequence analysis revealed the existence of two 99% identical retroelements flanking this exon. Unexpectedly, individuals expressing GHRd3 displayed a 2.7-kilobase deletion involving exon 3, which most likely results from an ancestral homologous recombination between the two retroelements. The lineage of these retroelements during primate evolution revealed the species specificity of the GHRd3 allele. These findings led us to propose a model underlying the existence of the sole GHRfl allele in most species. Such a retrovirus-mediated alternative splice mimicry, which clears up several as yet unexplained phenomena (i.e. the above-mentioned expression data, the Mendelian inheritance of GHR expression patterns, and the deletion of nonconsecutive exons in growth hormone resistant patients), represents a novel physiological mechanism accounting for protein diversity between and within species.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10764769     DOI: 10.1074/jbc.M001615200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  Pediatric pharmacogenetic and pharmacogenomic studies: the current state and future perspectives.

Authors:  Roberta Russo; Mario Capasso; Paolo Paolucci; Achille Iolascon
Journal:  Eur J Clin Pharmacol       Date:  2010-11-11       Impact factor: 2.953

Review 2.  Update on prognostic factors in acromegaly: Is a risk score possible?

Authors:  E Fernandez-Rodriguez; F F Casanueva; I Bernabeu
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

3.  Rapid method for growth hormone receptor exon 3 delete (GHRd3) SNP genotyping from archival human placental samples.

Authors:  Rebecca A Pelekanos; Varda S Sardesai; Marloes Dekker Nitert; Leonie K Callaway; Nicholas M Fisk; Penny L Jeffery
Journal:  Endocrine       Date:  2015-06-12       Impact factor: 3.633

4.  The growth hormone receptor polymorphism in patients with acromegaly: relationship to BMI and glucose metabolism.

Authors:  Sebahat Turgut; Fulya Akın; Ceylan Ayada; Senay Topsakal; Emrah Yerlikaya; Günfer Turgut
Journal:  Pituitary       Date:  2012-09       Impact factor: 4.107

5.  Growth hormone receptor is expressed in human breast cancer.

Authors:  M Gebre-Medhin; L G Kindblom; H Wennbo; J Törnell; J M Meis-Kindblom
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

6.  The growth hormone receptor (GHR) polymorphism in growth-retarded children with Cushing disease: lack of association with growth and measures of the somatotropic axis.

Authors:  L Drori-Herishanu; M Lodish; S Verma; E Bimpaki; M F Keil; A Horvath; C A Stratakis
Journal:  Horm Metab Res       Date:  2009-12-09       Impact factor: 2.936

7.  Comparison of biological specimens and DNA collection methods for PCR amplification and microarray analysis.

Authors:  Jasmine A Rethmeyer; Xiaoyu Tan; Ann Manzardo; Stephen R Schroeder; Merlin G Butler
Journal:  Clin Chem Lab Med       Date:  2013-05       Impact factor: 3.694

8.  Lack of an association between GHR exon 3 polymorphism and diabetic nephropathy in the Genetics of Kidneys in Diabetes (GoKinD) population.

Authors:  H F Gu; S Efendic; K Brismar
Journal:  Diabetologia       Date:  2008-09-05       Impact factor: 10.122

9.  The role of GHR and IGF1 genes in the genetic determination of African pygmies' short stature.

Authors:  Noémie S A Becker; Paul Verdu; Myriam Georges; Philippe Duquesnoy; Alain Froment; Serge Amselem; Yves Le Bouc; Evelyne Heyer
Journal:  Eur J Hum Genet       Date:  2012-10-10       Impact factor: 4.246

10.  Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly.

Authors:  Antonio Bianchi; Gherardo Mazziotti; Laura Tilaro; Vincenzo Cimino; Flora Veltri; Eleonora Gaetani; Giovanni Pecorini; Alfredo Pontecorvi; Andrea Giustina; Laura De Marinis
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.